RecruitingPhase 2/3

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

China40 participantsStarted 2025-05-02

Plain-language summary

The main objective of this study was to determine the efficacy of different doses of propranolol in the treatment of ulcerattion infantile hemangioma (IH).

Who can participate

Age range1 Month – 4 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. all patients with ulcer IH;
✓. children with ulcer IH treated with propranolol.

What they're measuring

Time to ulcer healing

Timeframe: 1.5 years

Trial details

NCT IDNCT06798363

SponsorWest China Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-30

Contact for this trial

Yi Ji

+862885423453 jijiyuanyuan@163.com

View on ClinicalTrials.gov More Infantile Hemangioma trials